PA GOODDOCTOR (01833.HK) +0.170 (+1.446%) Short selling $73.21M; Ratio 38.470% 's 2025 revenue grew by 13.7% YoY to RMB5.47 billion, while net profit and non-IFRS net profit amounted to RMB378 million and RMB414 million, respectively, indicating YoY increases of 5.2 ppts and 4.3 ppts in net profit margin and adjusted net profit margin to 6.9% and 7.6%, according to a report from UBS.UBS has raised its EPS forecast for PA GOODDOCTOR for each year from 2026 to 2028 to RMB0.22, RMB0.31, and RMB0.39. PA GOODDOCTOR's target price dropped from HKD16.5 to HKD14.5, with a Neutral rating.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-03-27 16:25.)Related News Jefferies Upgrades Ping An Good Doctor (01833.HK) to 'Hold', Raises TP to HKD12.4